Hospital
Campbell County Hma, LLC
Campbell County Hma, LLC was paid $10.07M by Medicaid between Jan 2018 and Dec 2024, across 105 billing codes. Its largest line is 99283, emergency room visit (moderate) — 40% of everything it billed.
33Billing provider infoCAMPBELL COUNTY HMA, LLC
LAFOLLETTE, TN 37766
LAFOLLETTE, TN 37766
33aNPI1639151301assigned 11/17/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.07M
24GClaims215,045
24DCodes billed105
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Tennessee
Rank by total paid#26 of 71
Median peer was paid$6.96M
This provider vs. median1.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 36,868 | $1.62M | |
| 2019 | 41,966 | $1.65M | |
| 2020 | 28,755 | $1.23M | |
| 2021 | 27,035 | $1.48M | |
| 2022 | 29,414 | $1.60M | |
| 2023 | 29,617 | $1.42M | |
| 2024incomplete | 21,390 | $1.07M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 40% | 20,696 | 18,126 | $4.01M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 30% | 13,408 | 11,221 | $2.98M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 14% | 5,765 | 4,653 | $1.36M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.8% | 3,025 | 2,698 | $386K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2.7% | 4,975 | 1,805 | $275K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.8% | 1,852 | 1,698 | $184K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.2% | 5,644 | 5,044 | $123K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.1% | 8,503 | 7,064 | $110K |
| G0378 | Hospital observation service, per hour | <1% | 1,000 | 441 | $80K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 346 | 238 | $72K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 23,453 | 18,050 | $61K |
| 84484 | <1% | 8,963 | 6,028 | $54K |
93 more codes
| 80053 | Comprehensive metabolic panel | <1% | 21,088 | $45K |
| 71045 | Radiologic examination, chest; single view | <1% | 10,382 | $30K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,537 | $28K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,753 | $25K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,796 | $23K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,914 | $22K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 9,538 | $22K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,003 | $19K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 308 | $16K |
| 36415 | Collection of venous blood by venipuncture | <1% | 16,201 | $13K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 737 | $12K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,726 | $12K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,935 | $7K |
| 83690 | <1% | 2,697 | $7K | |
| 94060 | <1% | 199 | $6K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 581 | $6K |
| 81001 | <1% | 8,818 | $5K | |
| 87070 | <1% | 1,354 | $4K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 953 | $4K |
| 81025 | <1% | 2,229 | $4K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 270 | $4K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 103 | $4K |
| 97597 | <1% | 135 | $3K | |
| 83880 | <1% | 670 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,466 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 313 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 88 | $3K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 56 | $2K |
| 87040 | <1% | 600 | $2K | |
| 94729 | <1% | 217 | $2K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 85 | $2K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 302 | $2K |
| 80061 | Lipid panel | <1% | 868 | $2K |
| 86403 | <1% | 414 | $2K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 109 | $2K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 13 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 46 | $1K |
| 94727 | <1% | 176 | $1K | |
| 83605 | <1% | 487 | $1K | |
| 74178 | <1% | 17 | $1K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 31 | $1K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 288 | $954.82 |
| 85027 | <1% | 991 | $953.52 | |
| 72100 | <1% | 61 | $872.80 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 453 | $865.85 |
| 93017 | <1% | 55 | $770.77 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 20 | $600.36 |
| 87400 | <1% | 73 | $598.61 | |
| 87081 | <1% | 235 | $595.53 | |
| 82550 | <1% | 409 | $585.20 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 32 | $513.15 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 329 | $504.97 |
| 83735 | <1% | 298 | $493.19 | |
| 85610 | <1% | 315 | $404.42 | |
| 85379 | <1% | 107 | $399.92 | |
| 82150 | <1% | 111 | $323.11 | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 13 | $316.58 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 210 | $291.32 |
| 84439 | <1% | 136 | $261.79 | |
| 82803 | <1% | 70 | $242.46 | |
| 96376 | <1% | 70 | $227.68 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 19 | $220.82 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 78 | $193.99 |
| 85730 | <1% | 162 | $167.21 | |
| 82962 | <1% | 128 | $159.83 | |
| 82607 | <1% | 110 | $155.99 | |
| 36600 | <1% | 70 | $122.64 | |
| 71271 | <1% | 21 | $103.13 | |
| 74022 | <1% | 17 | $89.12 | |
| 94761 | <1% | 16 | $88.48 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 27 | $72.29 |
| 86140 | <1% | 25 | $63.57 | |
| 87807 | <1% | 12 | $55.36 | |
| 82728 | <1% | 27 | $44.52 | |
| 82746 | <1% | 12 | $24.03 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 34 | $22.02 |
| 81003 | <1% | 13 | $17.05 | |
| 82565 | <1% | 15 | $11.16 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 66 | $9.89 |
| 84100 | <1% | 18 | $7.68 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,383 | $4.60 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 1,840 | $0.00 |
| 88342 | 0% | 53 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 519 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 1,122 | $0.00 |
| V2632 | Posterior chamber intraocular lens | 0% | 14 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 190 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 33 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 110 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 725 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 32 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 19 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.